NO20084950L - Ny anvendelse av terapeutisk nyttige peptider - Google Patents

Ny anvendelse av terapeutisk nyttige peptider

Info

Publication number
NO20084950L
NO20084950L NO20084950A NO20084950A NO20084950L NO 20084950 L NO20084950 L NO 20084950L NO 20084950 A NO20084950 A NO 20084950A NO 20084950 A NO20084950 A NO 20084950A NO 20084950 L NO20084950 L NO 20084950L
Authority
NO
Norway
Prior art keywords
pro
therapeutically useful
new use
useful peptides
biologically active
Prior art date
Application number
NO20084950A
Other languages
English (en)
Inventor
Tiina Jauhiainen
Riitta Korpela
Heikki Vapaatalo
Mats Ronnback
Original Assignee
Valio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Ltd filed Critical Valio Ltd
Publication of NO20084950L publication Critical patent/NO20084950L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/09—Other cheese preparations; Mixtures of cheese with other foodstuffs
    • A23C19/0921—Addition, to cheese or curd, of minerals, including organic salts thereof, trace elements, amino acids, peptides, protein hydrolysates, nucleic acids, yeast extracts or autolysate, vitamins or derivatives of these compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/147—Helveticus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Det beskrives prevensjon og terapi av endotelialdysfunksjon ved bruk av biologisk aktive peptider og produkter inneholdende disse. Særlig benyttes tripeptidene Ile-Pro-Pro (IPP) og Val-Pro-Pro (VPP) eller blandinger, konsentrater eller andre produkter inneholdende disse. Et spesifikt aspekt er å forbedre elastisiteten for blodkar ved å benytte nevnte biologisk aktive peptider.
NO20084950A 2006-05-15 2008-11-25 Ny anvendelse av terapeutisk nyttige peptider NO20084950L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FI2006/050194 WO2007132054A1 (en) 2006-05-15 2006-05-15 New use of therapeutically useful peptides

Publications (1)

Publication Number Publication Date
NO20084950L true NO20084950L (no) 2008-12-09

Family

ID=38693585

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084950A NO20084950L (no) 2006-05-15 2008-11-25 Ny anvendelse av terapeutisk nyttige peptider

Country Status (8)

Country Link
US (1) US20090111758A1 (no)
EP (1) EP2040732A4 (no)
JP (1) JP2009537492A (no)
CN (1) CN101443031A (no)
AU (1) AU2006343802A1 (no)
CA (1) CA2652388A1 (no)
NO (1) NO20084950L (no)
WO (1) WO2007132054A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1992352T3 (da) 2006-02-14 2014-06-10 Calpis Co Ltd Middel til anvendelse i forbyggelsen af aterosklerosis
FI122531B (fi) * 2009-09-30 2012-03-15 Valio Oy Juusto ja menetelmä sen valmistamiseksi
CN103275177B (zh) * 2013-06-24 2015-08-12 南京财经大学 具有肾素和ace双重抑制活性的小肽、其制备方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE402003C (sv) 1976-06-23 1982-02-22 Jonsereds Fabrikers Ab Anordning vid lastapparat med teleskopiskt forlengbar kranarm och med hydraulledningar uppburna av kranarmen
JPH064105A (ja) * 1992-06-17 1994-01-14 Yamaha Corp 誘導性負荷の駆動回路
JP2782142B2 (ja) 1992-07-23 1998-07-30 カルピス株式会社 アンジオテンシン変換酵素阻害剤及びその製造法
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6069129A (en) 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
AU7501801A (en) 2000-05-30 2001-12-11 Connective Tissue Imagineering Composition and method for enhancing elasticity of tissue
GB0026134D0 (en) * 2000-10-25 2000-12-13 Eurogene Ltd Peptides and their use
US6506129B2 (en) * 2001-02-21 2003-01-14 Archer C. C. Chen Golf club head capable of enlarging flexible area of ball-hitting face thereof
FI112031B (fi) 2002-02-25 2003-10-31 Valio Oy Biologisesti aktiivisen tuotteen uusi käyttö
BRPI0513237A (pt) 2004-07-12 2008-04-29 Dsm Assets B V hidrolisados de proteìna para diminuição de pressão sanguìnea
DK1992352T3 (da) 2006-02-14 2014-06-10 Calpis Co Ltd Middel til anvendelse i forbyggelsen af aterosklerosis

Also Published As

Publication number Publication date
WO2007132054A1 (en) 2007-11-22
AU2006343802A1 (en) 2007-11-22
EP2040732A4 (en) 2009-08-19
US20090111758A1 (en) 2009-04-30
EP2040732A1 (en) 2009-04-01
CN101443031A (zh) 2009-05-27
CA2652388A1 (en) 2007-11-22
JP2009537492A (ja) 2009-10-29

Similar Documents

Publication Publication Date Title
Ding et al. Transport of egg white ACE-inhibitory peptide, Gln-Ile-Gly-Leu-Phe, in human intestinal Caco-2 cell monolayers with cytoprotective effect
NO20076415L (no) GLP-1 pegylerte forbindelser
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
US11072634B2 (en) Inhibitors of transglutaminases
EA200601738A1 (ru) Модифицированные белки буганины, цитотоксины и способы их применения
EA201000424A1 (ru) Антитела к il-23
NO20064388L (no) Kaseinavledede peptider og terapeutiske anvendelser derav
NO20080626L (no) Inhibitorer av fibroblastaktiverende protein alfa
RU2009135802A (ru) Способ активации хелперных т-клеток и композиция для применения в данном способе
ATE556717T1 (de) Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus
IL169896A0 (en) Methods and compositions for administering therapeutic and diagnostic agents
CY1109353T1 (el) Ερυθροκυτταρα που περιεχουν αποϊμιναση αργινινης
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
NO20071714L (no) Fremgangsmateer for behandling av CD30 positive lymfomer
CL2008002092A1 (es) Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas.
NO20084950L (no) Ny anvendelse av terapeutisk nyttige peptider
BR0314666A (pt) Composição nutricional ou terapêutica utilizável para o tratamento de mamìferos para aumentar a atividade imune e método de tratar um mamìfero para aumentar a concentração de glutationa no tecido no referido mamìfero
Bi et al. A new class of β-carboline alkaloid-peptide conjugates with therapeutic efficacy in acute limb ischemia/reperfusion injury
MA32242B1 (fr) Article absorbant
NO20084190L (no) Anvendelse av VX-702 til behandling av revmatoid artritt
FR2915397B1 (fr) Composition pharmaceutique et/ou cosmetique contenant des principes actifs activateurs de l'aconitase
Shibata et al. Improvement of biological activity and proteolytic stability of peptides by coupling with a cyclic peptide
Freise et al. The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp) 10 promotes enzymatic activity of matrixmetalloproteinase-2 in vitro
Ramasami Sustainable Chemistry Research: Chemical and Biochemical Aspects
CN107383164B (zh) 一类用于促胶原分泌的超短肽及其应用

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application